We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Healthcare 11.35%
3 Financials 9.44%
4 Consumer Discretionary 8.31%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONEV icon
6076
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$307M
$62K ﹤0.01%
673
SMSI icon
6077
Smith Micro Software
SMSI
$16.2M
$62K ﹤0.01%
689
-733
-52% -$74.4K
TNON icon
6078
Tenon Medical
TNON
$2.96M
$62K ﹤0.01%
17
+9
+113% +$52.5K
SYRS
6079
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$62K ﹤0.01%
9,669
-233
-2% -$1.89K
GENE
6080
DELISTED
Genetic Technologies Ltd.
GENE
$62K ﹤0.01%
10,466
-40
-0.4% -$292
ONCT
6081
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$62K ﹤0.01%
3,484
-18,749
-84% -$402K
CLRG
6082
DELISTED
IndexIQ ETF Trust IQ U.S. Large Cap ETF
CLRG
$62K ﹤0.01%
2,198
+496
+29% +$15.4K
HEXO
6083
DELISTED
HEXO Corp. Common Shares
HEXO
$62K ﹤0.01%
25,385
-5,080
-17% -$14.5K
BRF icon
6084
VanEck Brazil Small-Cap ETF
BRF
$20.3M
$61K ﹤0.01%
4,018
-7,070
-64% -$108K
EQS icon
6085
Equus Total Return
EQS
$15.6M
$61K ﹤0.01%
37,125
+1,885
+5% +$3.86K
ESEA icon
6086
Euroseas
ESEA
$525M
$61K ﹤0.01%
3,617
-3,240
-47% -$61.2K
GALT icon
6087
Galectin Therapeutics
GALT
$317M
$61K ﹤0.01%
37,547
-21,309
-36% -$39.8K
KORE
6088
DELISTED
KORE Group Holdings
KORE
$61K ﹤0.01%
6,426
+2,868
+81% +$39.5K
OVB icon
6089
Overlay Shares Core Bond ETF
OVB
$48M
$61K ﹤0.01%
3,000
VLT icon
6090
Invesco High Income Trust II
VLT
$65.8M
$61K ﹤0.01%
6,193
-49
-0.8% -$536
ICVX
6091
DELISTED
Icosavax, Inc. Common Stock
ICVX
$61K ﹤0.01%
19,246
-95,348
-83% -$596K
CEI
6092
DELISTED
Camber Energy, Inc
CEI
$61K ﹤0.01%
6,274
+4,829
+334% +$81.5K
AWRE icon
6093
Aware
AWRE
$26M
$60K ﹤0.01%
33,452
+7,094
+27% +$15.2K
DAPP icon
6094
VanEck Digital Transformation ETF
DAPP
$231M
$60K ﹤0.01%
12,132
-2,620
-18% -$15.6K
EVTL icon
6095
Vertical Aerospace
EVTL
$107M
$60K ﹤0.01%
641
-623
-49% -$39.1K
IOBT
6096
DELISTED
IO Biotech
IOBT
$60K ﹤0.01%
22,060
-2,049
-8% -$7.6K
OWLT icon
6097
Owlet
OWLT
$182M
$60K ﹤0.01%
3,996
+841
+27% +$20.7K
SOS
6098
SOS Limited
SOS
$16.7M
$60K ﹤0.01%
973
-355
-27% -$33.3K
RPT.PRD
6099
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
$60K ﹤0.01%
1,372
+84
+7% +$4.11K
AWAY icon
6100
Amplify Travel Tech ETF
AWAY
$32.6M
$59K ﹤0.01%
3,745
+100
+3% +$1.77K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.